Patent · US Active

Methods for increasing efficacy of lipid formulated siRNA

US10053689B2 · kind B2 · utility

7Cited by
10References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 30, 2015
Grant dateAug 21, 2018
Priority date—
Expiry dateApr 30, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to methods for increasing the efficiency of siRNA administrations via pre-administration of an agent that lowers LDL receptor levels.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.